A growth consultant for medtech fixes the leaks that are specific to medical technology: long sales cycles, multiple stakeholders, regulated messaging, and high-value leads that quietly go cold. In medtech the cost of losing a qualified lead is high, so the systems that nurture and prioritize those leads matter more than aggressive top-of-funnel tactics.
The most common and most expensive leak is the gap between demo and close. One anonymized med-tech SaaS at $2.4M ARR was losing 67% of its leads after the demo. Building scoring and nurture automation recovered $400K in additional ARR in 90 days.
What a medtech growth consultant fixes
- Post-demo drop-off - the biggest leak in long-cycle medtech sales. Scoring and nurture keep high-value leads warm through a multi-month decision.
- Lead scoring - prioritizing the leads most likely to close so sales focuses where it matters across a long cycle.
- Attribution - clean measurement across a journey with many touches and stakeholders.
- Compliant lifecycle content - nurture that builds trust within regulatory constraints.
Why medtech is different
Medtech buyers move slowly and in groups. A clinical lead, a procurement stakeholder, and an economic buyer all weigh in, often over months. You cannot make loose claims, and you cannot afford to let a qualified lead cool because no one followed up. That makes systematic nurture, scoring, and attribution the core of medtech growth, not the periphery.
When to hire one
Hire a medtech growth consultant when qualified leads go cold in long cycles, you cannot measure which channels produce real pipeline, or follow-up depends on someone remembering. The systems get built and handed off in a 90-day sprint.
Running a medtech company losing leads in long sales cycles? Book a diagnostic call or try the free growth tools.